---
title: "Longtech: Net profit in the first half of 2025 decreased by 30.74% year-on-year"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/253970153.md"
description: "Longtech announced that in the first half of 2025, operating revenue was 806 million yuan, a year-on-year decrease of 10.40%. Net profit was 57.5095 million yuan, a year-on-year decrease of 30.74%. The company plans not to distribute cash dividends, not to issue bonus shares, and not to increase capital through reserves"
datetime: "2025-08-21T10:47:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/253970153.md)
  - [en](https://longbridge.com/en/news/253970153.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/253970153.md)
generator: "portal-rs"
---

# Longtech: Net profit in the first half of 2025 decreased by 30.74% year-on-year

Longtech announced that its operating revenue in the first half of 2025 was 806 million yuan, a year-on-year decrease of 10.40%. The net profit was 57.5095 million yuan, a year-on-year decrease of 30.74%. The company plans not to distribute cash dividends, not to issue bonus shares, and not to increase capital using reserves

### Related Stocks

- [300916.CN](https://longbridge.com/en/quote/300916.CN.md)

## Related News & Research

- [04:04 ETLa célébration du 11e anniversaire d'Anycubic approche : 11 ans, 11 millions d'idées](https://longbridge.com/en/news/297285709.md)
- [Democratic strategist: 'something's going on' when Trump 'can only deliver 52 percent' in South Carolina](https://longbridge.com/en/news/297204658.md)
- [Canada minister says he welcomes US clarification on French language requirements](https://longbridge.com/en/news/297196718.md)
- [Hegseth ignored CENTCOM, cut program ahead of Iran school strike: Report](https://longbridge.com/en/news/297352818.md)
- [Heidelberg Pharma, Huadong Medicine expand ADC collaboration to develop new drug candidates](https://longbridge.com/en/news/297291658.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**